140 related articles for article (PubMed ID: 38019249)
1. Frequencies of Diagnostically Significant Polymorphisms of Hereditary Breast Cancer Forms in BRCA1 and BRCA2 Genes in the Kazakh Population.
Svyatova G; Berezina G; Urazbayeva G; Murtazaliyeva A
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3899-3907. PubMed ID: 38019249
[TBL] [Abstract][Full Text] [Related]
2. Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age.
Turkovic L; Gurrin LC; Bahlo M; Dite GS; Southey MC; Hopper JL
BMC Cancer; 2010 Sep; 10():466. PubMed ID: 20807450
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of BRCA1/2 gene and pathologic characteristics from Kazakh population with sporadic breast cancer in northwestern China.
Yang SY; Aisimutula D; Li HF; Hu Y; Du X; Li J; Luan MX
Genet Mol Res; 2015 Oct; 14(4):13151-61. PubMed ID: 26535628
[TBL] [Abstract][Full Text] [Related]
5. Mutational spectrum of BRCA1/2 genes in Moroccan patients with hereditary breast and/or ovarian cancer, and review of BRCA mutations in the MENA region.
Elalaoui SC; Laarabi FZ; Afif L; Lyahyai J; Ratbi I; Jaouad IC; Doubaj Y; Sahli M; Ouhenach M; Sefiani A
Breast Cancer Res Treat; 2022 Jul; 194(1):187-198. PubMed ID: 35578052
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study.
Zayas-Villanueva OA; Campos-Acevedo LD; Lugo-Trampe JJ; Hernández-Barajas D; González-Guerrero JF; Noriega-Iriondo MF; Ramírez-Sánchez IA; Martínez-de-Villarreal LE
BMC Cancer; 2019 Jul; 19(1):722. PubMed ID: 31331294
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.
Cherbal F; Bakour R; Adane S; Boualga K; Benais-Pont G; Maillet P
Dis Markers; 2010; 28(6):377-84. PubMed ID: 20683152
[TBL] [Abstract][Full Text] [Related]
8. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
9. Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
Riedlova P; Janoutova J; Hermanova B
Mol Biol Rep; 2020 Apr; 47(4):2763-2769. PubMed ID: 32180084
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation.
Seong MW; Cho S; Noh DY; Han W; Kim SW; Park CM; Park HW; Kim SY; Kim JY; Park SS
Clin Genet; 2009 Aug; 76(2):152-60. PubMed ID: 19656164
[TBL] [Abstract][Full Text] [Related]
11. Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort.
Akter H; Sultana N; Martuza N; Siddiqua A; Dity NJ; Rahaman MA; Samara B; Sayeed A; Basiruzzaman M; Rahman MM; Rashidul Hoq M; Amin MR; Baqui MA; Woodbury-Smith M; Uddin KMF; Islam SS; Awwal R; Berdiev BK; Uddin M
BMC Med Genet; 2019 Sep; 20(1):150. PubMed ID: 31477031
[TBL] [Abstract][Full Text] [Related]
12. Complete BRCA mutation screening in breast and ovarian cancer predisposition families from a North-Eastern Romanian population.
Negura L; Uhrhammer N; Negura A; Artenie V; Carasevici E; Bignon YJ
Fam Cancer; 2010 Dec; 9(4):519-23. PubMed ID: 20567915
[TBL] [Abstract][Full Text] [Related]
13. Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection.
Ibrahim SS; Hafez EE; Hashishe MM
J Exp Clin Cancer Res; 2010 Jun; 29(1):82. PubMed ID: 20579331
[TBL] [Abstract][Full Text] [Related]
14. Identification of Variants (rs11571707, rs144848, and rs11571769) in the
Dobbin EAF; Medeiros JAG; Costa MSCR; Rodrigues JCG; Guerreiro JF; Kroll JE; Souza SJ; de Assumpção PP; Ribeiro-Dos-Santos Â; Santos SEBD; Burbano RMR; Fernandes MR; Santos NPCD
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33499154
[TBL] [Abstract][Full Text] [Related]
15. Next-generation sequencing of the BRCA1 and BRCA2 genes for the genetic diagnostics of hereditary breast and/or ovarian cancer.
Trujillano D; Weiss ME; Schneider J; Köster J; Papachristos EB; Saviouk V; Zakharkina T; Nahavandi N; Kovacevic L; Rolfs A
J Mol Diagn; 2015 Mar; 17(2):162-70. PubMed ID: 25556971
[TBL] [Abstract][Full Text] [Related]
16. Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.
Kwong A; Ng EK; Wong CL; Law FB; Au T; Wong HN; Kurian AW; West DW; Ford JM; Ma ES
PLoS One; 2012; 7(9):e43994. PubMed ID: 22970155
[TBL] [Abstract][Full Text] [Related]
17. Population frequencies of pathogenic alleles of BRCA1 and BRCA2: analysis of 173 Danish breast cancer pedigrees using the BOADICEA model.
Terkelsen T; Christensen LL; Fenton DC; Jensen UB; Sunde L; Thomassen M; Skytte AB
Fam Cancer; 2019 Oct; 18(4):381-388. PubMed ID: 31435815
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations in hereditary breast cancer.
Cipollini G; Tommasi S; Paradiso A; Aretini P; Bonatti F; Brunetti I; Bruno M; Lombardi G; Schittulli F; Sensi E; Tancredi M; Bevilacqua G; Caligo MA
Ann Oncol; 2004; 15 Suppl 1():I7-I13. PubMed ID: 15280181
[TBL] [Abstract][Full Text] [Related]
19. Is multiple SNP testing in BRCA2 and BRCA1 female carriers ready for use in clinical practice? Results from a large Genetic Centre in the UK.
Ingham SL; Warwick J; Byers H; Lalloo F; Newman WG; Evans DG
Clin Genet; 2013 Jul; 84(1):37-42. PubMed ID: 23050611
[TBL] [Abstract][Full Text] [Related]
20. Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy.
Cini G; Mezzavilla M; Della Puppa L; Cupelli E; Fornasin A; D'Elia AV; Dolcetti R; Damante G; Bertok S; Miolo G; Maestro R; de Paoli P; Amoroso A; Viel A
BMC Med Genet; 2016 Feb; 17():11. PubMed ID: 26852130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
